baber/WOPTO huggingface dataset:
Patent SI-2281563-T1 (SI)
Title: 2,4-Pyrimidinediamine compounds and their uses
Inventor: SINGH RAJINDER
IPC: A61K31/506
Filed: 2003-01-31
Abstract: The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signalling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in the treatment and prevention of diseases characterized by, caused by or associated with the release of chemical mediators via degranulation and other processes effected by activation of the IgE and/or IgG receptor signalling cascades.
Patent SI-1713830-T1 (SI)
Title: Anti-epcam immunoglobulins
Inventor: PETERS MALTE
IPC: C07K16/00
Filed: 2005-02-09
Abstract: The invention relates  inter alia  to a method of treating tumorous disease in a human patient by administering to the patient a human immunoglobulin specifically binding to the human EpCAM antigen, the immunoglobulin exhibiting a serum half-life of at least 15 days, the method comprising the step of administering the immunoglobulin no more frequently than once every week, preferably no more frequently than once every two weeks.
Patent SI-2125612-T1 (SI)
Title: Reactor and method for the production of hydrogen sulfide
Inventor: WOELFERT ANDREAS
IPC: B01J19/24
Filed: 2008-01-14
Abstract: The invention relates to a reactor (1) and a process for continuously preparing H2S by converting a reactant mixture which comprises essentially gaseous sulfur and hydrogen over a catalyst, comprising a sulfur melt (9) at least in a lower subregion (8) of the reactor (1), into which gaseous hydrogen is introduced. The catalyst is arranged in at least one U-shaped tube (21) which is partly in contact with the sulfur melt (9), the at least one U-shaped tube (21) having at least one entry orifice (23) on a limb (26) above the sulfur melt (9), through which the reactant mixture can enter the U-shaped tube (21) from a reactant region (10) of the reactor (1), having a flow path within the at least one U-shaped tube, along which the reactant mixture can be converted in a reaction region comprising the catalyst (22), and having at least one exit orifice (24) in another limb (27) through which a product can exit into a product region (7).
Patent SI-2170736-T1 (SI)
Title: Package with double hinged connector
Inventor: WEISS JACQUES
IPC: B65D85/08
Filed: 2008-07-18
Abstract: A container for smoking articles comprises at least two hingedly connected packs, each for housing a separate bundle of smoking articles. The container comprises: a first pack having a first wall; a second pack having a first wall; and a separate connector (10). The separate connector comprises a series of panels and subpanels to form a container according to an embodiment of the invention, the first sub-panels (16) of the second (14) and fourth (26) panels and the first sub-panel (22) of the third panel (20) are folded through 180 degrees about the vertical fold lines connecting them to the edges of the first panel (12) so that they overlie the first panel (12). The second sub-panels (18) of the second (14) and fourth (26) panels and the second sub-panel (24) of the third panel (20) are folded through 180 degrees about the vertical fold lines connecting them to the first sub-panels (16) of the second (14) and fourth (26) panels and the first sub-panel (22) of the third panel (20), respectively, so that the second-sub panels (18,24,18) of the second (14), third (20) and fourth (26) panels overlie the corresponding first-sub panels (16,22,16) thereof. To complete formation of the container, the outer surface of the first panel (12) is affixed to the first wall of a first pack and the inner surfaces of the second-sub panels (18,24,18) of the second (14), third (20) and fourth (26) panels are affixed to the first wall of a second pack.
Patent SI-2961752-T1 (SI)
Title: Substituted imidazopyridazines
Inventor: KOPPITZ MARCUS
IPC: C07D487/00
Filed: 2014-02-25
Abstract: The present invention relates to substituted imidazopyridazine compounds, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.
Patent SI-3055861-T1 (SI)
Title: Estimation of mixing factors to generate high-band excitation signal
Inventor: ATTI VENKATRAMAN S
IPC: G10L21/00
Filed: 2014-10-09
Abstract: A method includes generating a high-band residual signal based on a high-band portion of an audio signal. The method also includes generating a harmonically extended signal at least partially based on a low-band portion of the audio signal. The method further includes determining a mixing factor based on the high-band residual signal, the harmonically extended signal, and modulated noise. The modulated noise is at least partially based on the harmonically extended signal and white noise.
Patent DE-3783024-T2 (DE)
Inventor: HIROTA SADAO C O DAIICHI SEIYA
IPC: A61K31/535
Filed: 1987-12-18
Granted: 1993-04-15
Abstract: A topical preparation containing, as an active ingredient, 9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyr ido[1,2,3] [1,4]-benzoxazine-6-carboxylic acid or a salt thereof.
Patent DE-3789615-T2 (DE)
Inventor: GIRIJAVALLABHAN VIYYOOR MOOPIL
IPC: C07D307/20
Filed: 1987-12-09
Granted: 1994-07-21
Abstract: The disclosed invention is compounds represented by the formula <CHEM> and pharmaceutically acceptable acid addition, basic addition and quarternary amine salts thereof and pharmaceutically acceptable solvates thereof, wherein each Z is independently tetiary butyl, phenyl, naphthyl or adamantyl; substituted phenyl, wherein the substituents are one or more of halogen, lower alkoxy, phenoxy, nitrile, nitro, phenyslsulfonyl, loweralkylsulfonyl, oxazol-2-yl, lower alkanoyl, benzoyl, lower alkoxycarbonyl, lower alkyl, lower alkylthio, phenyl, phenylaminothiocarbonyl, or lower alkylaminothiocarbonyl; 4 or 6 membered unsubstituted or substituted heterocyclic ring containing at least one nitrogen with the remaining members of the ring being at least one carbon, and optionally sulfur or oxygen, wherein the substituents are one or more of carboxyl, hydroxymethyl, lower alkyl, loweralkylcarbonyl or aryl lower alkyl;  X and Y are each independently a bond, -O-, <CHEM> each Q is independently a divalent substituted or unsubstituted, straigh or branched chain lower alkanediyl, lower alkanediyl-cycloalkaneidyl-lower alkanediyl, lower alkenediyl, lower alkynediyl, phenylene, dihydrofurandiyl, tetrahydrofurandiyl, tetrahydropyrandiyl, or, loweralkanediyl-tetrahydrofurandiyl-loweralkanediyl, wherein the substituents are one or more of hydroxy, epoxy, fluorine, chlorine, azide, or amino; W is a monovalent substituted or unsubstituted aryl group or a heterocyclic single or fused ring containing from 4 to 10 ring atoms, at least one hetero atom of which is a nitrogen atom and the remaining ring atoms being at least one carbon and optionally sulfur or oxygen, wherein the substituents are one or more of hydroxy, oxo amino, carbamoyl, carboxyl, nitrile, nitro, lower alkoxy carbonyl, halogen, sulfamyl, lower alkyl, lower alkylthio, lower alkoxy, hydroxyloweralkyl, lower alkoxycarbonylloweralkyl, amino loweralkyl, carboxyloweralkyl, guanidino, thioureido, lower alkylsulfonylamino, aminocarbonylloweralkyl, allyloxycarbonylmethyl or carbamoyloxyloweralkyl; with the proviso that W cannot be substituted or unsubstituted isoxazolyl, and  W' is divalent W. The compounds have antiviral activity, antiinflammatory activity and are PAF inhibitors.
Patent DE-3850946-T2 (DE)
Inventor: SKEELS GARY WILLIAM
IPC: B01J29/06
Filed: 1988-12-13
Granted: 1994-12-01
Abstract: Molecular sieve compositions are prepared by extracting aluminium and substituting chromium and/or tin for extracted aluminium to give molecular sieve products containing framework chromium and/or tin atoms. The process of preparing the chromium and/or tin-containing molecular sieves involves contacting a starting molecular sieve with a solution or slurry of at least one of a fluoro salt of chromium or a fluoro salt of tin under effective process conditions to provide for aluminium extraction and substitution of chromium and/or tin. Generally, the product molecular sieve has a unit molecular formula of  (MwAlxSiy)02 where "M" is at least one of chromium or tin; and "w" "x" and "y" represent that mole fractions of "M", aluminium and silicon, respectively, present as framework tetrahedral oxide units, said mole fractions being such that they are within the triagonal area defined by points A, B, and C of Figure 13, having the following parameters: <TABLE> n
Patent DE-3856335-T2 (DE)
Inventor: YAMAMOTO SHUJI
IPC: C12N15/12
Filed: 1988-01-08
Granted: 2000-01-27
Abstract: A new peptide which accelerates the activation of Protein C by thrombin, has an 118 aminoacid chain (structure given) with optional N and C terminal additions (also of defined structure). Also claimed are DNA sequences coding for the peptide. Prepn. of the peptide is by expression of a plasmid contg. a DNA sequence coding for the peptide (e.g. pSV2TMD1, pSV2TMD5) in a transformant organism such as E.coli K-12, Saccharomyces cerevisiae, HeLa cells, or Chinese hamster ovary.
Patent DE-3875585-T2 (DE)
Inventor: BRIGGS CATHERINE BEVERLEY ANNE
IPC: G03C1/00
Filed: 1988-10-25
Granted: 1993-03-11
Abstract: Water soluble surface active compounds are provided having the formula <CHEM>  wherein each of R<1> and R<2> independently is hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted cycloalkyl, or substituted or unsubstituted aryl, provided that not both R<1> and R<2> are hydrogen,  and each of x and y independently is an integer from 3 to 6. The compounds are particularly useful as coating aids and dispersing aids in the preparation of photographic materials.
Patent DE-3883959-T2 (DE)
Inventor: WIGGLESWORTH PAUL
IPC: B01F5/06
Filed: 1988-12-01
Granted: 1994-01-05
Abstract: An apparatus for making a post-foaming gel comprising, a device for pumping a gel base, a device (34) for measuring the flow rate of the pumped gel base, a device (51) responsive to the measuring device (34) for pumping a foaming agent at a flow rate in a predetermined ratio to the flow rate of the gel base, a device (38) for introducing the foaming agent to the gel base, and a device (84) for forming the gel or emulsion from the introducing device (38).
Patent DE-3887089-T2 (DE)
Inventor: BLANKENSHIP ROBERT MITCHELI
IPC: G21F9/16
Filed: 1988-11-04
Granted: 1994-05-26
Abstract: A method of solidification or encapsulation of compositions containing a substantially continuous aqueous phase comprising uniformly incorporating into the compositions core-shell polymer particles and subsequently neutralizing the polymer particles by incorporating into the compositions an organic or inorganic base. The neutralized polymer particles swell and absorb substantially all the aqueous phase.
Patent TR-199900233-T2 (TR)
Inventor: MASUYAMA AKIHIRO
IPC: A23L1/30
Filed: 1997-08-06
Abstract: Hiçbir sorun ile karsilasilmadan güvenlik içinde sürekli olarak uygulanabilecek ve stresin neden oldugu fiziksel semptomlari hafifleten ya da önleyen stres önleyici ilaçlar ve stres önleyici etkileri olan islevsel yiyecekler. Ilaçlarin içindeki aktif madde, Lactobacillus türüne ait olan laktik asit bakterisinin kullanilmasi ile mayalanan hayvan sütleriyle hazirlanmis asit sütleridir; islevsel yiyeceklerin içindeyse bu ilaçlar bulunur ve stres önleyici etkileri vardir.
Patent DE-60002308-T2 (DE)
Inventor: REBEAUD ISABELLE
IPC: A23L35/00
Filed: 2000-03-30
Granted: 2004-02-19
Abstract: The invention relates to a method for the production of a pizza-type food product for hand consumption, a device for carrying out said method and the product thus obtained. The inventive method consists in the following: the raw pizza dough (1) is prepared; the various ingredients selected for the pizza are placed in a conventional manner on top of said raw dough (1), the dough and ingredients are cooked in an oven, the garnished cooked dough is folded over when removed from the oven  resulting in a format that corresponds to that of the desired product, whereby the upper (5) and lower edges (7) of the folded dough are substantially juxtaposed, and a strip of dough (3) is applied to the slice and any ingredients that are flush with said substantially juxtaposed edges.
Patent DE-60002960-T2 (DE)
Inventor: AUBAREDE FRANCIS
IPC: F16F9/32
Filed: 2000-02-09
Granted: 2004-02-19
Abstract: The invention concerns a McPherson strut suspension comprising a lower spring retainer (32) pressed on an element (33) integral with a shock-absorbing body. The lower spring retainer (32) is mobile in translation (T) relative to an element (33) integral with a shock-absorbing body (A) according to a selected position adjustment. Adapting shapes (34) in the element (33) provide a position indexing by co-operating with adapting shapes (35) in the lower spring retainer (32) while the coil spring remains prestressed during adjustment by appropriate means.
Patent DE-60006583-T2 (DE)
Inventor: BROWN WILLIAM
IPC: C07D215/14
Filed: 2000-12-15
Granted: 2004-09-30
Abstract: The present invention is directed to a compound of general formula (I),wherein R<1 >is selected from phenyl, pyridinyl, thiophenyl, furanyl, imidazolyl; each phenyl ring and heteroaromatic ring optionally and independently being further substituted by 1, 2 or 3 substituents selected from straight and branched C1-C6 alkyl, NO2, CF3, C1-C6 alkoxy, chloro, fluoro, bromo, and iodo, as well as their pharmaceutically acceptable salts. The invention includes pharmaceutical compositions comprising these compounds and the use of the compounds in therapy, in particular in the management of pain.
Patent DE-60006693-T2 (DE)
Inventor: ADALSTEINSSON ORN
IPC: A61K35/54
Filed: 2000-09-07
Granted: 2004-09-30
Abstract: The invention is directed to a composition and method for the treatment and prevention of inflammation and inflammatory related disorders. The composition is glucosamine in combination with an egg product. It is generally preferred that the egg product is obtained from an avian which has been hyperimmunized with an immunogenic mixture and/or which contains an anti-inflammatory composition.
Patent DE-60007507-T2 (DE)
Inventor: POULET SERGE
IPC: B60R9/058
Filed: 2000-04-04
Granted: 2004-09-09
Abstract: The load-carrying bar, normally used in conjunction with at least one other, consists of a central and/or main section (8), a locking member (15) and a regulator (27) with two threaded components (28, 29). One of the threaded components (29) is connected to an actuator (33) via a torque limiter (39) which prevents excessive force being applied to the regulator when it is being rotated in the direction required to fasten the bar while allowing greater force to be applied to undo it.
Patent DE-60012076-T2 (DE)
Inventor: ROBERTS DAVID ALLEN
IPC: C09K23/00
Filed: 2000-05-03
Granted: 2004-11-25
Abstract: A prewetted cleaning wipe for cleaning surfaces and having low volatile organic chemical and low nonvolatile residue properties comprising a wipe substrate wetted with an aqueous solution of high purity water and an effective amount of an acetylenic alcohol surface active agent. The surface active agent is preferably an acetylenic diol. More preferably, the surface active agent is an acetylenic glycol. Preferred acetylenic diols include dimethyl octynediol and tetramethyl decynediol.
Patent DE-60012160-T2 (DE)
Inventor: FORSLUND KJELL
IPC: B04B3/00
Filed: 2000-03-03
Granted: 2004-11-25
Abstract: Apparatus for separating a fiber suspension is provided including a housing with an upper chamber in the upper portion thereof, a rotor rotatably mounted in the housing, a first rotary screen mounted for rotation with the rotor and dividing the housing into a first screen chamber and a first accept chamber, a second screen radially outward from the rotor defining a second screen chamber, the diameter of the first rotary screen being less than that of the second screen, the first rotary screen being located within the second screen, an inlet, a reject outlet, at least one accept outlet and a stator within the first rotary screen including at least one pulse member for creating a pulse within the first rotary screen, the diameter of the housing being less than the diameter of the second screen and the first rotary screen being separated from the second screen chamber and located at least partially within the second screen chamber.
Patent DE-60012935-T2 (DE)
Inventor: KESSELL MARGARET
IPC: C09K23/54
Filed: 2000-05-25
Granted: 2005-08-18
Abstract: A dispersion comprises at least 30 per cent by weight of particles of a metal oxide having an average primary particle size of less than 200 nm dispersed in a siloxane fluid dispersing medium and a dispersing agent wherein said metal oxide particles are hydrophoobic, and the dispersing agent is polylkylene oxide/polyalkylsiloxane block copolymer comprising at least 30 per cent by weight of the copolymer of polyalkylsiloxane. The dispersion is particularly suitable for use as an ingredient in sunscreening cosmetics.
Patent DE-60014008-T2 (DE)
Inventor: MONTGON ALEXIS
IPC: B66C23/70
Filed: 2000-11-23
Granted: 2005-09-08
Abstract: The crane boom has a main arm (3) pivoting on a rotary head (1) and an additional arm (7) extending from the main arm and pivoted at its front end. A counter-weight (14) is articulated to the rear of the main arm. The additional arm and counterweight balancer are connected by a pulley system (10,10') at the front end of the main arm and a second pulley system (28,28') at the rear of the main arm. The pulley systems are connected by a cable which is controlled by a hydraulic cylinder.
Patent DE-60019746-T2 (DE)
Inventor: CLANCY LLEWELLYN
IPC: G01N33/50
Filed: 2000-02-10
Granted: 2006-05-11
Abstract: The present invention is concerned with methods for determining predisposition to infection in a subject exposed to stressors. In particular the present invention is concerned with methods of assessing the risk of susceptibility to infection in a subject by monitoring the levels of IgA and IgA1.
Patent DE-60028367-T2 (DE)
Inventor: MALVY CLAUDE
IPC: A61K31/711
Filed: 2000-03-09
Granted: 2007-02-08
Abstract: Oligonucleotides capable of modifying or inhibiting in vivo or in vitro expression of a target gene wherein the oligonucleotide has an antisense sequence, at least one secondary structure, and optionally a supplementary nucleotide sequence located at one and/or both ends of the antisense sequence and wherein the secondary structure disintegrates upon attachment of the oligonucleotide to a target nucleic acid; a pharmaceutical composition containing such an oligonucleotide as an active ingredient; and a method of treatment using such an oligonucleotide.
Patent DE-60029105-T2 (DE)
Inventor: SJOELUND JAN
IPC: H04M7/00
Filed: 2000-08-02
Granted: 2006-12-21
Abstract: The invention provides a hybrid arrangement, which allows an existing circuit switched telephony network to be deployed on a packet switched network. The circuit switched underlying transport network is replaced with that of an IP based package switched network (30), while the circuit switched infrastructure, such as terminals, telephone exchanges and the like are retained. In preferred embodiments of the invention, both a subscriber (10, 11, 20, 21) and a local telephone exchange (40, 50) are connected to, and separated by, an IP based packet switched network such as the Internet (30). Signalling between the subscriber (10, 11, 20, 21) and exchange (40, 50) are effected using a standard user to network protocol, such as V5.1 for PSTN and ISDN BRI or DSS1 for ISDN PRI. This standard user to network protocol is overlaid on an IP based network protocol, such as TCP or UDP on IP.
Patent DE-60031701-T2 (DE)
Inventor: ORTON KEVIN R
IPC: A61J1/05
Filed: 2000-09-21
Granted: 2007-09-06
Abstract: A container has at least one wall. A reservoir is defined within the wall. The reservoir can be sealed. At least one electrode extends at least partially into the sealed reservoir. An electrical contact element is connected to the electrode to facilitate electrically coupling the a signal generator or other electrical supply to the electrode.
Patent DE-60034625-T2 (DE)
Inventor: HARTLEY JOHN G
IPC: H01J37/305
Filed: 2000-03-18
Granted: 2008-01-03
Abstract: An e-beam lithographic system capable of in situ registration. The system has an optics section such as a VAIL lens. A controllable stage moves a substrate with respect to the beam axis to place substrate writing fields beneath the beam. A field locking target between the optics section and the stage has an aperture sized to permit the beam to write a target field on the substrate. The field locking target includes alignment or registration marks around the aperture. A differential interferometric system measures the relative positions of the field locking target and the stage and controls stage position. The beam patterns the substrate on a field by field basis. As the stage is moving into position for each field, the beam is swept until it hits the alignment marks, thereby checking system alignment. The beam control data, i.e., coil currents necessary to hit the marks are stored, and drift correction values calculated from the beam control data. Meanwhile, pattern beam control is compensated by the drift correction values. <IMAGE>
Patent DE-60034865-T2 (DE)
Inventor: KIM SOO IN
IPC: A61P37/00
Filed: 2000-12-12
Granted: 2007-09-06
Abstract: The invention belongs to the field of biologically active peptides specifically stimulating antiviral, antimicrobial and antitumor activity of the human and animal immune system.
Patent DE-60100364-T2 (DE)
Inventor: REINER ALBERTO
IPC: A61K9/16
Filed: 2001-11-20
Granted: 2003-12-04
Abstract: Water-soluble non-effervescent pharmaceutical compositions comprising a water-soluble salt of a NSAID having an arylpropionic or arylacetic structure and a mixture of at least two pharmaceutically acceptable completely salified di- or tricarboxylic organic acids, in amounts and proportions as to mask the taste of the NSAID salt in aqueous solution are described. The compositions according to the present invention, even without flavors, provide perfectly drinkable aqueous solutions that, after ingestion, do not elicit the unpleasant irritating feeling typical of known formulation.